172 related articles for article (PubMed ID: 34982445)
1. Effectiveness and adverse effects of anakinra in treatment of rheumatoid arthritis: a systematic review.
Bedaiwi MK; Almaghlouth I; Omair MA
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7833-7839. PubMed ID: 34982445
[TBL] [Abstract][Full Text] [Related]
2. Anakinra for rheumatoid arthritis.
Mertens M; Singh JA
Cochrane Database Syst Rev; 2009 Jan; (1):CD005121. PubMed ID: 19160248
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis.
Nikfar S; Saiyarsarai P; Tigabu BM; Abdollahi M
Rheumatol Int; 2018 Aug; 38(8):1363-1383. PubMed ID: 29737371
[TBL] [Abstract][Full Text] [Related]
4. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
[TBL] [Abstract][Full Text] [Related]
5. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
Cohen S; Hurd E; Cush J; Schiff M; Weinblatt ME; Moreland LW; Kremer J; Bear MB; Rich WJ; McCabe D
Arthritis Rheum; 2002 Mar; 46(3):614-24. PubMed ID: 11920396
[TBL] [Abstract][Full Text] [Related]
6. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.
Zintzaras E; Dahabreh IJ; Giannouli S; Voulgarelis M; Moutsopoulos HM
Clin Ther; 2008 Nov; 30(11):1939-55. PubMed ID: 19108784
[TBL] [Abstract][Full Text] [Related]
7. Anakinra for rheumatoid arthritis: a systematic review.
Mertens M; Singh JA
J Rheumatol; 2009 Jun; 36(6):1118-25. PubMed ID: 19447938
[TBL] [Abstract][Full Text] [Related]
8. [Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis].
Botsios C; Sfriso P; Furlan A; Ostuni P; Biscaro M; Fiocco U; Todesco S; Punzi L
Reumatismo; 2007; 59(1):32-7. PubMed ID: 17435840
[TBL] [Abstract][Full Text] [Related]
9. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
Furst DE
Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
[TBL] [Abstract][Full Text] [Related]
10. The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
Clark W; Jobanputra P; Barton P; Burls A
Health Technol Assess; 2004 May; 8(18):iii-iv, ix-x, 1-105. PubMed ID: 15130461
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G; Bresnihan B; Bear MB; McCabe D;
Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
[TBL] [Abstract][Full Text] [Related]
12. A randomised trial evaluating anakinra in early active rheumatoid arthritis.
Scott IC; Ibrahim F; Simpson G; Kowalczyk A; White-Alao B; Hassell A; Plant M; Richards S; Walker D; Scott DL
Clin Exp Rheumatol; 2016; 34(1):88-93. PubMed ID: 26842950
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
Karanikolas G; Charalambopoulos D; Vaiopoulos G; Andrianakos A; Rapti A; Karras D; Kaskani E; Sfikakis PP
Rheumatology (Oxford); 2008 Sep; 47(9):1384-8. PubMed ID: 18603660
[TBL] [Abstract][Full Text] [Related]
14. Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Ruiz Garcia V; Burls A; Cabello JB; Vela Casasempere P; Bort-Marti S; Bernal JA
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007649. PubMed ID: 28884785
[TBL] [Abstract][Full Text] [Related]
15. Anakinra treatment of patients with rheumatoid arthritis.
Calabrese LH
Ann Pharmacother; 2002; 36(7-8):1204-9. PubMed ID: 12086555
[TBL] [Abstract][Full Text] [Related]
16. Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.
Schiff MH
Drugs; 2004; 64(22):2493-501. PubMed ID: 15516150
[TBL] [Abstract][Full Text] [Related]
17. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.
Singh JA; Christensen R; Wells GA; Suarez-Almazor ME; Buchbinder R; Lopez-Olivo MA; Ghogomu ET; Tugwell P
CMAJ; 2009 Nov; 181(11):787-96. PubMed ID: 19884297
[TBL] [Abstract][Full Text] [Related]
18. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
[TBL] [Abstract][Full Text] [Related]
19. Secondary failure to treatment with recombinant human IL-1 receptor antagonist in Chinese patients with rheumatoid arthritis.
Bao J; Yue T; Liu W; Zhang Q; Zhou L; Xu HJ; Dai SM
Clin Rheumatol; 2011 May; 30(5):697-701. PubMed ID: 21221689
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
